mild pleurisy NSAIDs Addition of antimalarials for long-term management Most moderate SLE manifestations Oral glucocorticoids 0.25–0.5 mg/kg prednisone (or equivalent) Addition of antimalarials ...

Objectives Patients with SLE take multiple medications. Within a large prospective longitudinal SLE cohort, we characterised ...

Management Intravenous methylprednisolone ... that progressed to coma over a few days. Her medical history was significant for a diagnosis of SLE 3 years earlier, which was made on the basis ...

call for an improvement in the current therapeutic management of SLE. From a pathogenesis standpoint, unbalanced immune homeostasis and aberrant autoreactivity in SLE associate with inflammatory ...

Bullous systemic lupus erythematosus (BSLE ... can also advise them on possible complications and ways to manage them. Medical News Today has strict sourcing guidelines and relies on peer-reviewed ...

He holds cross-appointments with the Institute of Health Policy Management and Evaluation (IHPME) and Institute of Medical Sciences graduate ... His research is focused on patients with systemic lupus ...

EULAR/ACR SLE classification criteria were not linked to mortality or hospitalization, a developed ominosity model adequately predicted mortality.

Henry W. Chen, MD, from the University of Texas Southwestern Medical Center in Dallas, and colleagues examined the incidence and prevalence of ASCVD among individuals with CLE, SLE, and psoriasis ...